newsfilter
← Latest News
GlobeNewswire·

Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program

BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") announces it has received a Small Business Innovation Research (SBIR) Phase I award from the